Gliocidin selectively kills glioblastoma cells by inhibiting nucleotide synthesis, showing potential as a therapeutic option in combination with temozolomide.
Small brain-penetrating molecule offers hope for treating aggressive brain tumors
- Post author:
- Post published:November 21, 2024
- Post category:uncategorized
- Post comments:0 Comments